Aided by government agencies, Indian drug companies have, in just one year, managed to develop medicines for four rare diseases that cut down their annual cost of treatment by as much as 100 times.
Cost-effective drugs for 14 rare diseases, including sickle cell, to be launched soon: Mandaviya- The New Indian Express newindianexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newindianexpress.com Daily Mail and Mail on Sunday newspapers.
Indian pharmaceutical companies Biophore and its subsidiary Zenara Pharma in Hyderabad get approval from the CDSCO for manufacturing and marketing of neuro disorder drug.
Hyderabad-based Biophore India Pharmaceuticals has announced that it has received approval from he Central Drugs Standard Control Organisation (CDSCO) for manufacturing and marketing of Cannabidiol active ingredient in India.Its subsidiary, .